Martin Samuel Bates (CIK 0001709024)

Latest company ownership

Shares held
16,968
Last filed at
Jun 18, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 14, 2024 Jun 18, 2024 Celldex Therapeutics, Inc. CFO Sell 20.0 -17,172 -37.91% ✗ $608.3K
May 30, 2024 Jun 3, 2024 Celldex Therapeutics, Inc. CFO Sell 17.5 -35,000 -58.21% ✗ $1.2M
Aug 11, 2022 Aug 15, 2022 Celldex Therapeutics, Inc. CFO Sell 20.0 -20,000 -16.39% ✗ $730.5K
Dec 23, 2021 Dec 28, 2021 Celldex Therapeutics, Inc. CFO Sell 7.5 -9,500 -28.04% ✓ $399K
Nov 15, 2021 Nov 17, 2021 Celldex Therapeutics, Inc. CFO Sell 7.5 -9,500 -26.11% ✓ $413.9K
Aug 10, 2021 Aug 12, 2021 Celldex Therapeutics, Inc. CFO Sell 22.5 -2,738 -5.36% ✗ $123.9K
Jun 9, 2020 Jun 10, 2020 Celldex Therapeutics, Inc. CFO Buy 91.3 +9,750 989.85% ✗ $29.7K